Hydroxychloroquine for COVID-19: Variation in Regional Political Preferences Predicted New Prescriptions after President Trump's Endorsement

Madanay, F; McDevitt, RC; Ubel, PA

Madanay, F (通讯作者),Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA.

JOURNAL OF HEALTH POLITICS POLICY AND LAW, 2022; 47 (4): 429

Abstract

Context: On March 19, 2020, President Donald Trump endorsed using hydroxychloroquine for COVID-19 treatment despite inconclusive evidence of the drug'......

Full Text Link